Stay informed on issues important to patients of Montgomery Cancer Center.
Montgomery Cancer Center among first in nation to treat advanced prostate cancer patients with Provenge
Montgomery Cancer Center is the first facility in Alabama and among the first in the nation to treat advanced prostate cancer patients with a promising new therapy. Read More
Mon, 09 Dec 2013 00:01:15 +0000
Nexavar Approved for Metastatic Differentiated Thyroid Cancer
The U.S. Food and Drug Administration (FDA) has approved Nexavar® (sorafenib) for the treatment of metastatic differentiated thyroid cancer. Differentiated thyroid cancer is the most common type of thyroid cancer and can often be cured with surgery and radioactive iodine (RAI) treatment. In some cases, however, the cancer is resistant to RAI. RAI-resistant thyroid cancers […]read more
The most state-of-the-art technology of its kind in Alabama, TrueBeam™ from Varian Medical Systems integrates advanced imaging and motion management technologies to target tumors with sub-millimeter accuracy – and short treatment times.
Take a minute to visit the campus of Montgomery Cancer Center - without leaving your computer. Take a tour.
© Montgomery Cancer Center, 4145 Carmichael Road Montgomery, AL 36106